Open in Screener

WVE

Wave Life Sciences Ltd

Jun 05 • 04:00PM ET

5.73

-0.36 -5.91 %

Healthcare • Biotechnology • Singapore • Small • NASD

Peers: NTLA BEAM IONS CRSP EDIT ALNY BMRN KRYS RYTM INCY

| Held by: IWM VXF IBB IWO VTWO SCHA XPH DFAS VHT IWC

Index	RUT	P/E	-	EPS (ttm)	-1.05	Insider Own	17.97%	Shs Outstand	192.34M	Perf Week	-12.92%
Market Cap	1.10B	Forward P/E	-	EPS next Y	-1.29	Insider Trans	36.04%	Shs Float	158.44M	Perf Month	-21.40%
Enterprise Value	573.58M	PEG	-	EPS next Q	-0.30	Inst Own	78.46%	Short Float	11.22%	Perf Quarter	-56.33%
Income	-183.59M	P/S	15.35	EPS this Y	8.12%	Inst Trans	-9.72%	Short Ratio	3.74	Perf Half Y	-19.75%
Sales	71.80M	P/B	2.15	EPS next Y	-16.41%	ROA	-42.11%	Short Interest	17.77M	Perf YTD	-66.29%
Book/sh	2.66	P/C	2.02	EPS next 5Y	1.02%	ROE	-53.11%	52W High	21.73 -73.63%	Perf Year	-15.11%
Cash/sh	2.83	P/FCF	-	EPS past 3/5Y	16.10% 20.52%	ROIC	-35.37%	52W Low	5.02 14.14%	Perf 3Y	33.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	127.08% 16.31%	Gross Margin	87.47%	Volatility	7.30% 5.65%	Perf 5Y	-15.36%
Dividend TTM	-	EV/Sales	7.99	EPS Y/Y TTM	-27.41%	Oper. Margin	-274.21%	ATR (14)	0.40	Perf 10Y	-63.96%
Dividend Ex-Date	-	Quick Ratio	11.26	Sales Y/Y TTM	-31.58%	Profit Margin	-255.70%	RSI (14)	34.21	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	11.26	EPS Q/Q	54.82%	SMA20	-10.84%	Beta	-1.26	Target Price	23.83
Payout	-	Debt/Eq	0.03	Sales Q/Q	316.85%	SMA50	-16.62%	Rel Volume	0.83	Prev Close	6.09
Employees	317	LT Debt/Eq	0.01	Earnings	Apr 28 BMO	SMA200	-42.54%	Avg Volume	4.75M	Price	5.73
IPO	Nov 11, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.81% 352.57%	Trades		Volume	3,979,275	Change	-5.91%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-26	Resumed	Truist	Buy	$15
Feb-05-26	Initiated	BofA Securities	Buy	$38
Dec-12-25	Reiterated	Wedbush	Outperform	$20 → $33
Dec-09-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$27
Oct-20-25	Initiated	Wells Fargo	Overweight	$18
Aug-04-25	Initiated	Canaccord Genuity	Buy	$19
Jul-28-25	Initiated	Oppenheimer	Outperform	$24
Jul-16-25	Initiated	Citigroup	Buy	$16
Jun-11-25	Resumed	Raymond James	Outperform	$14
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$10
Apr-08-25	Initiated	Wedbush	Outperform	$18
Feb-25-25	Initiated	Jefferies	Buy	$26
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$22
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5

Show Previous Ratings

Jun-02-26 08:30AM	Eco Wave Power Featured for Second Time in NVIDIA Founder and CEO Jensen Huang's GTC Keynote, as Company Advances Taiwan Wave Energy Project (PR Newswire) -9.11%
Jun-01-26 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
May-20-26 06:43AM	Immunovants potential autoimmune blockbuster; Waves RNA editing update (BioPharma Dive)
May-19-26 09:49AM	Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 (PR Newswire)
May-18-26 04:30PM	Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing (GlobeNewswire) -5.47%
04:05PM	Loading…
May-13-26 04:05PM	Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-29-26 08:30AM	Wave Life Sciences Ltd. Q1 2026 Earnings Call Summary (Moby) -6.25%
03:05AM	WAVE Life Sciences Ltd (WVE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Apr-28-26 07:37AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press) +8.36%
07:30AM	Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
Apr-22-26 08:30AM	Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 (GlobeNewswire)
Apr-21-26 04:01PM	Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States (GlobeNewswire)
Apr-15-26 04:01PM	Wave Life Sciences Announces Proposed Redomiciliation to the United States (GlobeNewswire)
Apr-03-26 01:45PM	Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors (Barrons.com)
Mar-27-26 08:35AM	Waves stock crashes 50% on Phase I obesity data (Clinical Trials Arena)
02:48PM	Loading…
Mar-26-26 02:48PM	Dow dips, Nasdaq falls as oil surges, Trump says Iran 'better get serious' (Proactive) -49.59%
12:30PM	Wave Life Sciences shares plummet on weight loss therapy update (Proactive)
09:40AM	Wave Plunges More Than 50% After Obesity Shot Falls Short (Bloomberg)
09:40AM	Wave Life Sciences Crashes 56% As 'Body Composition' Fat-Loss Drug Underwhelms (Investor's Business Daily)
07:30AM	Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 (GlobeNewswire)
06:46AM	Wave crashes on obesity drug update; Kodiaks reboot pays dividends (BioPharma Dive)
Mar-05-26 08:30AM	Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference (GlobeNewswire)
Mar-02-26 07:05AM	Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near (MarketBeat)
Feb-28-26 01:26PM	Wave Life Sciences Ltd. (WVE): A Bull Case Theory (Insider Monkey)
02:14AM	Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings (Insider Monkey)
Feb-27-26 12:39PM	WAVE Life Sciences Q4 Earnings Call Highlights (MarketBeat) -9.31%
Feb-26-26 04:09PM	WAVE Life Sciences Ltd (WVE) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline with ... (GuruFocus.com) +5.64%
12:15PM	Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Wave Life Sciences Ltd. Q4 2025 Earnings Call Summary (Moby)
07:49AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Loading…
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire)
Feb-23-26 08:30AM	Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Feb-22-26 06:15AM	Bank of America Predicts Up to 240% Jump for These 2 Strong Buy Stocks (TipRanks)
Feb-19-26 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026 (GlobeNewswire)
Feb-18-26 07:38PM	Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment (Insider Monkey)
02:02AM	BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)'s Growth, Projecting Peak Sales Above $11B (Insider Monkey)
Feb-16-26 12:23PM	Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program (Insider Monkey)
Feb-07-26 03:33AM	Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment (Insider Monkey)
Feb-05-26 10:12AM	Microsoft downgraded, Snap upgraded: Wall Street's top analyst calls (The Fly)
Feb-03-26 12:30PM	Wave Life Sciences price target raised to $50 from $47 at Clear Street (TipRanks)
Feb-02-26 02:16PM	Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path (Benzinga)
07:30AM	Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
03:31AM	GSK walks away from pioneering Wave RNA editing drug (BioPharma Dive)
Jan-12-26 07:30AM	Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (GlobeNewswire)
Jan-06-26 04:28PM	Arrowhead Says Its Gene Silencer Doubled Zepbound's Weight Loss (Investor's Business Daily)
11:26AM	Zepbound Boost Gets a Lift From Arrowhead's Drug. The Question Is Whether Patients Will Pay. (Barrons.com)
07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks)
Jan-05-26 08:30AM	Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.96%
Jan-02-26 10:50AM	Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target (Insider Monkey) -6.18%
Dec-31-25 11:25AM	Wave Life Sciences' (WVE) RNA Obesity Drug WVE-007 Shows Potential to Match GLP-1 Efficacy Without Muscle Loss (Insider Monkey)
Dec-30-25 11:46PM	H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) (Insider Monkey)
Dec-22-25 10:18PM	Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial (Insider Monkey) +12.45%
Dec-17-25 09:45AM	Share Offerings Prompt Huge Insider Buying in These 3 Biotechs (24/7 Wall St.)
Dec-14-25 02:40PM	Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial (Insider Monkey)
Dec-11-25 04:28PM	Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss (Investor's Business Daily) -17.20%
10:15AM	WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? (Zacks)
07:13AM	Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7% (Investor's Business Daily)
Dec-10-25 05:27PM	Golden Cross Alert: 3 Stocks With Major Upside Potential (MarketBeat) -5.07%
Dec-09-25 09:50PM	Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +15.06%
07:39PM	Why Wave Life Sciences Stock Crushed it Again Today (Motley Fool)
02:24PM	Wave Life Sciences (WVE) Soars to 6-Year High on Obesity Drug Clinical Trial (Insider Monkey)
Dec-08-25 06:50PM	Why Wave Life Sciences Stock Vaulted 146% Higher on Monday (Motley Fool) +147.26%
05:01PM	Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More (Motley Fool)
04:51PM	Wave Life Sciences Ltd. (WVE): A Bull Case Theory (Insider Monkey)
04:09PM	Wave Life Sciences Just Targeted Fat Loss, Specifically. Shares Skyrocketed 115%. (Investor's Business Daily)
04:01PM	Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire)
03:44PM	Wave Life skyrockets on obesity drug trial, Strategy buys bitcoin (Yahoo Finance Video)
12:46PM	Obesity Biotechs' Gains Hit Shares of Eli Lilly, Novo Nordisk (Barrons.com)
07:30AM	Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss (GlobeNewswire)
05:32AM	Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar (BioPharma Dive)
Dec-07-25 04:00PM	Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025 (GlobeNewswire)
Nov-16-25 10:13PM	Jefferies Maintains "Buy" Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning (Insider Monkey)
Nov-13-25 06:00AM	WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: Promising Clinical Advances and ... (GuruFocus.com)
Nov-10-25 08:45AM	Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -10.31%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Nov-07-25 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-06-25 07:00PM	CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-04-25 08:30PM	Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek 2025 (GlobeNewswire)
08:30AM	Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025 (GlobeNewswire)
Oct-30-25 05:53AM	Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? (Zacks)
Oct-29-25 10:50PM	Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day (GlobeNewswire) +8.83%
04:15PM	Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day (GlobeNewswire)
03:42PM	Wave Life Sciences stock soars after promising clinical data (Investing.com)
Oct-10-25 09:57AM	Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? (Zacks) -7.20%
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
08:30AM	Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-05-25 09:30AM	B. Riley aggressive buyer of Wave Life on material disconnect (TipRanks)
Sep-03-25 07:48AM	Wave shares sink on new study results for RNA editing drug (BioPharma Dive) -16.84%
07:30AM	Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Aug-29-25 05:09AM	Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins (Insider Monkey)
Aug-03-25 06:25AM	Oppenheimer Predicts Up to 590% Rally for These 2 Strong Buy Stocks (TipRanks)
Jul-31-25 05:01AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ... (GuruFocus.com)
Jul-30-25 09:00AM	Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Jul-29-25 09:48AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-24-25 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-23-25 08:30AM	Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 (GlobeNewswire) +7.94%
Jul-15-25 08:59AM	Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions (Insider Monkey)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

M.D.Dr. Paul B. Bolno M.B.A.

Founder & DirectorDr. Gregory L. Verdine Ph.D.

CFO & Principal Accounting OfficerMr. Kyle B. Moran CFA

Chief Technology OfficerDr. Chandra Vargeese Ph.D.

Senior VP of Corporate Development & Head of Emerging AreasDr. Christopher Francis Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 26 '26	Buy	6.08	5,305,782	32,265,431	23,508,791	Mar 30 08:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 27 '26	Buy	6.43	2,495,623	16,046,856	26,004,414	Mar 30 08:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 30 '26	Buy	6.50	971,091	6,312,092	26,975,505	Mar 30 08:30 PM
Francis Chris	See Remarks	Feb 26 '26	Option Exercise	4.28	33,194	141,920	79,767	Feb 27 09:00 PM
Francis Chris	See Remarks	Feb 26 '26	Sale	15.05	33,194	499,593	61,867	Feb 27 09:00 PM
Moran Kyle	Chief Financial Officer	Feb 09 '26	Sale	13.45	3,588	48,259	134,385	Feb 11 09:03 PM
BOLNO PAUL	President and CEO	Feb 09 '26	Sale	13.45	10,480	140,956	275,520	Feb 11 09:02 PM
Francis Chris	See Remarks	Feb 09 '26	Sale	13.45	1,883	25,326	61,867	Feb 11 09:01 PM
Vargeese Chandra	See Remarks	Feb 09 '26	Sale	13.45	3,228	43,417	408,246	Feb 11 09:00 PM
KYLE MORAN	Officer	Feb 09 '26	Proposed Sale	13.45	3,564	47,936		Feb 09 09:30 PM
Chris Francis	Officer	Feb 09 '26	Proposed Sale	13.45	1,870	25,152		Feb 09 09:29 PM
PAUL BOLNO	Officer	Feb 09 '26	Proposed Sale	13.45	10,411	140,028		Feb 09 09:27 PM
Francis Chris	See Remarks	Jan 02 '26	Option Exercise	3.14	9,375	29,438	34,375	Jan 06 09:30 PM
Francis Chris	See Remarks	Jan 02 '26	Sale	16.03	9,375	150,260	25,000	Jan 06 09:30 PM
GSK plc	10% Owner	Dec 11 '25	Buy	19.00	1,470,000	27,930,000	18,245,691	Dec 15 04:32 PM
Rawcliffe Adrian	Director	Dec 08 '25	Option Exercise	5.97	42,000	250,740	54,700	Dec 10 09:45 PM
Rawcliffe Adrian	Director	Dec 08 '25	Sale	15.00	42,000	630,000	12,700	Dec 10 09:45 PM
Wagner Heidi L	Director	Dec 08 '25	Option Exercise	5.97	14,000	83,580	51,930	Dec 10 09:45 PM
Wagner Heidi L	Director	Dec 08 '25	Sale	13.50	14,000	189,000	44,930	Dec 10 09:45 PM
HENRY CHRISTIAN O	Director	Dec 08 '25	Option Exercise	5.07	87,000	440,790	54,700	Dec 10 09:45 PM
HENRY CHRISTIAN O	Director	Dec 08 '25	Sale	14.65	93,445	1,369,324	12,700	Dec 10 09:45 PM
Tan Aik Na	Director	Dec 08 '25	Option Exercise	4.85	119,230	578,270	70,400	Dec 10 09:45 PM
Tan Aik Na	Director	Dec 08 '25	Sale	13.58	134,218	1,823,158	25,400	Dec 10 09:45 PM
Verdine Gregory L.	Director	Dec 08 '25	Sale	13.47	20,000	269,461	275,217	Dec 10 09:45 PM
Francis Chris	See Remarks	Dec 08 '25	Option Exercise	4.78	441,031	2,107,183	147,349	Dec 10 09:45 PM
Francis Chris	See Remarks	Dec 08 '25	Sale	14.57	441,031	6,427,085	25,000	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 09 '25	Option Exercise	9.51	86,000	818,120	139,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 08 '25	Option Exercise	3.43	210,000	721,300	189,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 08 '25	Sale	14.77	210,000	3,102,000	89,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 09 '25	Sale	20.03	50,036	1,001,979	89,218	Dec 10 09:45 PM
CORRIGAN MARK	Director	Dec 08 '25	Sale	13.48	16,115	217,297	28,815	Dec 10 09:45 PM
KYLE MORAN	Officer	Dec 09 '25	Proposed Sale	18.52	86,000	1,592,720		Dec 09 04:24 PM
Henry Family Trust	Affiliate	Dec 08 '25	Proposed Sale	18.52	93,445	1,730,601		Dec 08 07:08 PM
HEIDI L WAGNER	Director	Dec 08 '25	Proposed Sale	7.49	14,000	104,860		Dec 08 04:39 PM
KYLE MORAN	Officer	Dec 08 '25	Proposed Sale	7.49	210,000	1,572,900		Dec 08 04:37 PM
CHRISTOPHER FRANCIS	Officer	Dec 08 '25	Proposed Sale	7.49	483,602	3,622,179		Dec 08 04:36 PM
GREGORY VERDINE	Director	Dec 08 '25	Proposed Sale	7.49	20,000	149,800		Dec 08 04:35 PM
ADRIAN RAWCLIFFE	Director	Dec 08 '25	Proposed Sale	7.49	42,000	314,580		Dec 08 04:34 PM
MARK CORRIGAN	Director	Dec 08 '25	Proposed Sale	7.49	16,115	120,701		Dec 08 04:34 PM
AIK NA TAN	Director	Dec 08 '25	Proposed Sale	13.58	134,218	1,823,158		Dec 08 04:29 PM
Rawcliffe Adrian	Director	Nov 13 '25	Sale	6.79	16,115	109,421	12,700	Nov 14 09:00 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 13 '25	Buy	6.69	1,000	6,688	18,203,009	Nov 14 06:14 PM
ADRIAN RAWCLIFFE	Director	Nov 13 '25	Proposed Sale	6.96	16,115	112,080		Nov 13 04:25 PM
Verdine Gregory L.	Director	Aug 22 '25	Sale	10.00	10,000	100,000	285,217	Aug 26 09:40 PM
BOLNO PAUL	President and CEO	Aug 22 '25	Sale	10.10	217,351	2,194,810	121,000	Aug 26 09:40 PM
PAUL BOLNO	Director	Aug 22 '25	Proposed Sale	9.76	217,351	2,121,346		Aug 22 04:41 PM
GREGORY VERDINE	Director	Aug 22 '25	Proposed Sale	9.76	25,000	244,000		Aug 22 04:38 PM
Tan Aik Na	Director	Aug 15 '25	Option Exercise	9.13	21,000	191,730	61,388	Aug 19 08:00 PM
Tan Aik Na	Director	Aug 15 '25	Sale	9.25	21,000	194,250	40,388	Aug 19 08:00 PM
AIK NA TAN	Director	Aug 15 '25	Proposed Sale	9.25	21,000	194,250		Aug 15 04:59 PM
HENRY CHRISTIAN O	Director	Aug 13 '25	Sale	8.81	9,670	85,193	29,645	Aug 13 08:00 PM
Christian Henry	Director	Aug 13 '25	Proposed Sale	7.70	9,670	74,459		Aug 13 04:02 PM
TAKANASHI KEN	Director	Aug 05 '25	Sale	8.75	4,872	42,630	5,716,303	Aug 07 08:00 PM
Tan Aik Na	Director	Aug 05 '25	Sale	8.75	1,127	9,861	14,988	Aug 07 08:00 PM
Verdine Gregory L.	Director	Jun 13 '25	Sale	6.95	30,000	208,500	282,517	Jun 13 08:00 PM
GREGORY VERDINE	Director	Jun 13 '25	Proposed Sale	7.20	30,000	216,000		Jun 13 04:44 PM

Open in Screener

PACB

Pacific Biosciences of California Inc

Jun 05 • 04:00PM ET

1.45

-0.18 -11.04 %

Healthcare • Medical Devices • USA • Small • NASD

PACB Pacific Biosciences of California Inc daily Stock Chart

Peers: ILMN BIO BRKR TWST A QGEN WAT MTD DHR TMO

| Held by: ARKK ARKG VTI IWM VXF IWN IBB SCHA VTWO PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.43	Insider Own	7.93%	Shs Outstand	310.49M	Perf Week	-2.68%
Market Cap	450.37M	Forward P/E	-	EPS next Y	-0.47	Insider Trans	-3.21%	Shs Float	285.97M	Perf Month	-15.20%
Enterprise Value	877.78M	PEG	-	EPS next Q	-0.13	Inst Own	52.49%	Short Float	20.96%	Perf Quarter	5.07%
Income	-128.58M	P/S	2.81	EPS this Y	77.47%	Inst Trans	-4.13%	Short Ratio	9.71	Perf Half Y	-40.33%
Sales	160.03M	P/B	190.29	EPS next Y	-14.15%	ROA	-15.65%	Short Interest	59.93M	Perf YTD	-22.46%
Book/sh	0.01	P/C	1.63	EPS next 5Y	39.45%	ROE	-273.55%	52W High	2.73 -46.89%	Perf Year	45.00%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	-9.18% -	ROIC	-18.23%	52W Low	0.99 46.97%	Perf 3Y	-89.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.64% 15.19%	Gross Margin	38.16%	Volatility	11.22% 8.75%	Perf 5Y	-94.45%
Dividend TTM	-	EV/Sales	5.49	EPS Y/Y TTM	81.29%	Oper. Margin	-87.67%	ATR (14)	0.13	Perf 10Y	-84.59%
Dividend Ex-Date	-	Quick Ratio	4.87	Sales Y/Y TTM	5.04%	Profit Margin	-80.34%	RSI (14)	50.95	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	5.65	EPS Q/Q	98.11%	SMA20	7.67%	Beta	2.30	Target Price	2.46
Payout	-	Debt/Eq	296.79	Sales Q/Q	0.07%	SMA50	0.13%	Rel Volume	1.05	Prev Close	1.63
Employees	485	LT Debt/Eq	296.67	Earnings	May 07 AMC	SMA200	-13.71%	Avg Volume	6.17M	Price	1.45
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	78.83% -6.92%	Trades		Volume	6,483,584	Change	-11.04%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20

Show Previous Ratings

May-26-26 09:05AM	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing (GlobeNewswire)
May-21-26 04:05PM	PacBio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +5.04%
May-19-26 09:00AM	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology (Business Wire)
May-11-26 09:05AM	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss (GlobeNewswire)
May-08-26 08:30AM	Pacific Biosciences of California, Inc. Q1 2026 Earnings Call Summary (Moby) -14.55%
04:33PM	Loading…
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press)
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	Loading…
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby)
08:21AM	Loading…
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

PresidentMr. Christian O. Henry M.B.A.

CFO & Principal Accounting OfficerMr. James R. Gibson II

Chief Operating OfficerMr. Mark Van Oene Ph.D.

Co-FounderDr. Stephen Turner Ph.D.

Ph.D.Dr. Brett Atkins J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM

Open in Screener

DNA

Ginkgo Bioworks Holdings Inc

Jun 05 • 04:00PM ET

8.22

-0.83 -9.17 %

Healthcare • Biotechnology • USA • Small • NYSE

DNA Ginkgo Bioworks Holdings Inc daily Stock Chart

Peers: INCY KYMR NUVL BMRN RYTM VKTX KRYS AXSM MDGL NBIX

| Held by: VTI IWM VXF THNQ IWN KOMP IBB SCHA VTWO PRFZ

Index	RUT	P/E	-	EPS (ttm)	-5.39	Insider Own	25.22%	Shs Outstand	50.25M	Perf Week	-12.27%
Market Cap	536.97M	Forward P/E	-	EPS next Y	-3.77	Insider Trans	-3.20%	Shs Float	46.61M	Perf Month	-18.45%
Enterprise Value	567.33M	PEG	-	EPS next Q	-1.05	Inst Own	54.34%	Short Float	9.71%	Perf Quarter	26.46%
Income	-304.39M	P/S	3.80	EPS this Y	23.28%	Inst Trans	-1.91%	Short Ratio	3.54	Perf Half Y	-8.77%
Sales	141.31M	P/B	1.09	EPS next Y	12.95%	ROA	-25.61%	Short Interest	4.52M	Perf YTD	-1.08%
Book/sh	7.55	P/C	1.41	EPS next 5Y	-	ROE	-54.63%	52W High	17.58 -53.24%	Perf Year	13.69%
Cash/sh	5.82	P/FCF	-	EPS past 3/5Y	51.73% -7.49%	ROIC	-35.65%	52W Low	5.37 53.07%	Perf 3Y	-87.55%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-29.11% 17.29%	Gross Margin	36.49%	Volatility	12.12% 8.85%	Perf 5Y	-97.92%
Dividend TTM	-	EV/Sales	4.01	EPS Y/Y TTM	39.96%	Oper. Margin	-211.99%	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.15	Sales Y/Y TTM	-40.48%	Profit Margin	-215.41%	RSI (14)	46.79	Recom	3.67
Dividend Gr. 3/5Y	- -	Current Ratio	5.15	EPS Q/Q	17.32%	SMA20	-3.14%	Beta	1.81	Target Price	8.50
Payout	-	Debt/Eq	0.93	Sales Q/Q	-59.70%	SMA50	2.61%	Rel Volume	1.19	Prev Close	9.05
Employees	485	LT Debt/Eq	0.93	Earnings	May 07 AMC	SMA200	-13.93%	Avg Volume	1.28M	Price	8.22
IPO	Apr 19, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.76% -54.64%	Trades		Volume	1,519,685	Change	-9.17%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform	$3.50 → $2.50
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell	$3 → $1.25
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy	$6
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight	$5
May-18-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Mar-02-22	Resumed	Cowen	Outperform	$12
Feb-23-22	Initiated	Goldman	Neutral	$7
Feb-01-22	Initiated	BofA Securities	Neutral	$6
Jan-28-22	Initiated	BofA Securities	Buy	$8
Jan-07-22	Initiated	BTIG Research	Buy	$12
Nov-29-21	Initiated	Jefferies	Buy	$16
Oct-13-21	Initiated	Raymond James	Outperform	$14.50
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy	$14

Show Previous Ratings

May-26-26 12:33PM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery (PR Newswire)
May-12-26 10:30AM	The $59B Quiet Shift Reshaping How Patients Access Care (PR Newswire)
May-07-26 04:05PM	Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab (PR Newswire) -13.47%
May-06-26 09:29AM	Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q1 2026 Result (GuruFocus.com)
Apr-30-26 08:01AM	Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation (PR Newswire) +12.80%
03:01PM	Loading…
Mar-07-26 03:01PM	Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen (Benzinga)
Mar-02-26 08:00AM	Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure (PR Newswire)
Feb-28-26 12:07AM	Ginkgo Bioworks Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 08:02PM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... (GuruFocus.com) -30.48%
11:50AM	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter (Benzinga)
08:30AM	Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
Feb-26-26 04:26PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business (PR Newswire)
Feb-25-26 07:35AM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.87%
Feb-19-26 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation (PR Newswire) +8.27%
Feb-18-26 08:00AM	Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products (PR Newswire)
06:15PM	Loading…
Feb-17-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Feb-10-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks) -9.06%
Feb-06-26 06:26AM	Ginkgo, OpenAI Cut Protein Costs by 40% (GuruFocus.com) +21.39%
Feb-05-26 02:00PM	Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark (PR Newswire)
Feb-04-26 06:15PM	Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today (Zacks) -5.92%
Jan-29-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors (Zacks)
Jan-23-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -6.36%
Jan-14-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-13-26 08:00AM	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks) -5.72%
Dec-31-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts (Zacks)
Dec-22-25 01:21PM	Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach (PR Newswire) +8.52%
Dec-17-25 08:00AM	Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment (PR Newswire)
Dec-09-25 08:00AM	Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety (PR Newswire)
Dec-05-25 08:33AM	Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PC (PR Newswire)
08:00AM	Loading…
Dec-03-25 08:00AM	STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy (PR Newswire)
Nov-18-25 08:00AM	Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health (PR Newswire)
Nov-07-25 04:00AM	Ginkgo Bioworks Holdings Inc (DNA) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... (GuruFocus.com) -20.80%
Nov-06-25 04:05PM	Ginkgo Bioworks Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-05-25 07:46AM	Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2025 Result (GuruFocus.com)
Nov-03-25 08:00AM	Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium (PR Newswire)
Oct-31-25 08:00AM	Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture (PR Newswire) +8.16%
Oct-30-25 04:05PM	Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation (PR Newswire)
Oct-28-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Oct-23-25 08:00AM	Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program (PR Newswire)
Oct-22-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Oct-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know (Zacks) -12.37%
Oct-09-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.28% -11.29%
Oct-03-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know (Zacks) -7.87%
Sep-30-25 12:39PM	Ginkgo Bioworks Holdings Stock Scores RS Rating Upgrade (Investor's Business Daily) +10.20%
Sep-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Advances While Market Declines: Some Information for Investors (Zacks) -6.64%
Sep-04-25 08:00AM	Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium (Business Wire)
Aug-29-25 04:05PM	Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions (PR Newswire) -13.02%
Aug-20-25 08:01AM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry (PR Newswire)
Aug-13-25 09:30AM	Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average (Zacks) +14.71%
Aug-12-25 08:01AM	Ginkgo Automation Appoints Brian?O'Sullivan as Head of Commercial to Accelerate External Growth (PR Newswire)
Aug-08-25 03:46AM	Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... (GuruFocus.com) -8.69%
Aug-07-25 05:01PM	Ginkgo Bioworks Reports Second Quarter 2025 Financial Results (PR Newswire)
Jul-31-25 09:30AM	Ginkgo Bioworks awarded $4.66M contract by PNNL (TipRanks)
08:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation (PR Newswire)
Jul-30-25 09:01AM	Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy (PR Newswire)
Jul-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.31%
Jul-17-25 09:01AM	Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire)
Jul-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-10-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why (Zacks) -7.51%
Jul-01-25 06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know (Zacks)
May-21-25 04:05PM	Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer (PR Newswire) -7.38% -7.43%
May-08-25 11:36PM	Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.35%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.79% +14.73%
05:00PM	Ginkgo Bioworks Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 07:50AM	Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.56%
Apr-30-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:00AM	Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors (PR Newswire)
Apr-29-25 04:00PM	Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation (PR Newswire) -7.98%
Apr-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Apr-22-25 09:00AM	Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
09:00AM	Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
Apr-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know (Zacks)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +11.23%
Apr-10-25 09:55AM	Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet (Zacks) +7.67%
09:00AM	Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain (PR Newswire)
Apr-01-25 10:26AM	Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
09:35AM	Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks (Zacks)
Mar-27-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) -7.13%
Mar-21-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +5.91%
Mar-14-25 09:35AM	After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) +7.89%
Mar-05-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why (Zacks)
Feb-25-25 05:00PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -11.47%
Feb-21-25 09:00AM	Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab (PR Newswire) -5.34%
Feb-20-25 08:01AM	Ginkgo Bioworks Partners with HaDEA in Up to 24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care (PR Newswire) -9.86%
Feb-18-25 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation (PR Newswire) -6.52%
Feb-06-25 08:01AM	Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series (PR Newswire) -16.38%
Jan-29-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jan-23-25 08:01AM	Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) (PR Newswire)
Jan-13-25 08:01AM	Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors (PR Newswire) -9.41%
Jan-09-25 11:38AM	Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics (GlobeNewswire)
08:00AM	Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-17-24 12:00PM	All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy (Zacks)
08:11AM	Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program (PR Newswire)
Nov-12-24 05:01PM	Ginkgo Bioworks Reports Third Quarter 2024 Financial Results (PR Newswire)
08:01AM	Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing (PR Newswire)
Nov-05-24 07:00AM	Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation (PR Newswire)
Sep-24-24 07:01AM	NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture (PR Newswire)

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Co-FounderDr. Jason Kelly Ph.D.

Co-FounderDr. Reshma P. Shetty

FounderMr. Thomas Knight Jr.

Co-Founder & Head of StrategyMr. Austin Che Ph.D.

Co-Founder & CTOMr. Bartholomew Canton Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coen Steven P.	See remarks	May 22 '26	Sale	8.33	307	2,559	50,704	May 26 05:04 PM
Coen Steven P.	Officer	May 22 '26	Proposed Sale	8.33	307	2,559		May 22 03:25 PM
Che Austin	Officer	May 13 '26	Proposed Sale	8.28	2,200	18,216		May 13 10:39 AM
Coen Steven P.	See remarks	Apr 17 '26	Sale	7.95	324	2,576	50,268	Apr 20 05:02 PM
Coen Steven P.	Officer	Apr 17 '26	Proposed Sale	7.95	324	2,576		Apr 17 03:37 PM
Che Austin	Officer	Apr 15 '26	Proposed Sale	7.78	2,200	17,116		Apr 15 09:37 AM
Coen Steven P.	See remarks	Apr 13 '26	Sale	6.41	33,171	212,759	49,849	Apr 14 05:00 PM
Canton Barry	10% Owner	Apr 10 '26	Sale	6.43	124,727	802,494	436,422	Apr 13 05:00 PM
Shetty Reshma P.	See remarks	Apr 10 '26	Sale	6.43	124,727	802,494	436,422	Apr 13 05:00 PM
Coen Steven P.	Officer	Apr 13 '26	Proposed Sale	6.41	33,171	212,762		Apr 13 03:17 PM
Che Austin	Officer	Apr 13 '26	Proposed Sale	6.41	40,893	262,292		Apr 13 03:16 PM
Shetty Reshma P.	See remarks	Apr 08 '26	Sale	6.93	13,155	91,164	351,684	Apr 10 05:02 PM
Shetty Reshma P.	See remarks	Apr 09 '26	Sale	6.40	13,116	83,903	338,568	Apr 10 05:02 PM
Canton Barry	10% Owner	Apr 08 '26	Sale	6.93	13,155	91,164	351,684	Apr 10 05:01 PM
Canton Barry	10% Owner	Apr 09 '26	Sale	6.40	13,116	83,903	338,568	Apr 10 05:01 PM
Kelly Jason R	See remarks	Apr 09 '26	Sale	6.40	109,767	702,179	316,483	Apr 10 05:01 PM
Kelly Jason R	See remarks	Apr 08 '26	Sale	6.93	97,015	672,314	426,250	Apr 10 05:01 PM
Shetty Reshma P.	Officer	Apr 10 '26	Proposed Sale	6.43	124,727	802,531		Apr 10 03:46 PM
Canton Barry	Officer	Apr 09 '26	Proposed Sale	6.40	13,116	83,906		Apr 09 04:20 PM
Kelly Jason R	Officer	Apr 09 '26	Proposed Sale	6.40	109,767	702,201		Apr 09 04:13 PM
Kelly Jason R	Officer	Apr 08 '26	Proposed Sale	6.93	97,015	672,343		Apr 08 04:14 PM
Canton Barry	Officer	Apr 08 '26	Proposed Sale	6.93	13,155	91,168		Apr 08 04:14 PM
Coen Steven P.	See remarks	Mar 16 '26	Sale	6.74	708	4,768	9,099	Mar 18 05:00 PM
Coen Steven P.	Officer	Mar 16 '26	Proposed Sale	6.74	708	4,769		Mar 16 04:13 PM
Che Austin	Officer	Mar 11 '26	Proposed Sale	6.31	2,200	13,882		Mar 11 10:14 AM
Che Austin	Officer	Feb 04 '26	Proposed Sale	8.80	2,200	19,360		Feb 04 09:52 AM
Coen Steven P.	See remarks	Jan 20 '26	Sale	8.92	972	8,667	8,321	Jan 22 04:12 PM
Coen Steven P.	Officer	Jan 20 '26	Proposed Sale	8.92	972	8,667		Jan 20 04:15 PM
Che Austin	Officer	Jan 07 '26	Proposed Sale	9.16	2,200	20,152		Jan 07 10:09 AM
Coen Steven P.	See remarks	Dec 15 '25	Sale	8.89	736	6,540	7,488	Dec 16 05:11 PM
Coen Steven P.	Officer	Dec 15 '25	Proposed Sale	8.89	736	6,540		Dec 15 04:20 PM
Che Austin	Officer	Dec 10 '25	Proposed Sale	9.54	2,200	20,988		Dec 10 11:09 AM
Che Austin	Officer	Nov 12 '25	Proposed Sale	8.50	2,200	18,700		Nov 12 10:06 AM
Coen Steven P.	See remarks	Oct 17 '25	Sale	13.65	1,312	17,907	6,738	Oct 21 04:56 PM
Coen Steven P.	Officer	Oct 21 '25	Proposed Sale	15.00	5,609	84,135		Oct 21 02:53 PM
Coen Steven P.	Officer	Oct 21 '25	Proposed Sale	13.65	1,312	17,908		Oct 21 01:59 PM
Che Austin	Officer	Oct 08 '25	Proposed Sale	15.21	2,200	33,462		Oct 08 09:43 AM
Coen Steven P.	See remarks	Oct 01 '25	Sale	15.00	5,609	84,135	5,503	Oct 03 05:01 PM
HENRY CHRISTIAN O	Director	Sep 09 '25	Sale	11.06	10,000	110,600	24,310	Sep 10 04:06 PM
HENRY CHRISTIAN O	Director	Sep 08 '25	Sale	10.92	10,000	109,200	34,310	Sep 10 04:06 PM
Che Austin	Officer	Sep 10 '25	Proposed Sale	10.78	2,200	23,716		Sep 10 09:51 AM
HENRY CHRISTIAN O	Director	Sep 09 '25	Proposed Sale	11.06	10,000	110,600		Sep 09 11:06 AM
HENRY CHRISTIAN O	Director	Sep 08 '25	Proposed Sale	10.92	10,000	109,209		Sep 08 12:19 PM
Coen Steven P.	See remarks	Aug 22 '25	Sale	12.40	310	3,843	11,112	Aug 26 04:10 PM
Che Austin	Officer	Aug 06 '25	Proposed Sale	14.10	2,200	31,020		Aug 06 09:48 AM
Coen Steven P.	See remarks	Jul 17 '25	Sale	9.84	1,084	10,669	10,679	Jul 21 04:28 PM
Dmytruk Mark E.	Officer	Jul 17 '25	Proposed Sale	9.84	640	6,299		Jul 17 05:20 PM
Che Austin	Officer	Jul 09 '25	Proposed Sale	11.18	2,200	24,596		Jul 09 12:07 PM
Che Austin	Officer	Jun 23 '25	Proposed Sale	8.43	99	835		Jun 23 09:54 AM
Che Austin	Officer	Jun 20 '25	Proposed Sale	8.66	99	857		Jun 20 09:50 AM
Che Austin	Officer	Jun 18 '25	Proposed Sale	8.46	99	838		Jun 18 09:41 AM
Che Austin	Officer	Jun 17 '25	Proposed Sale	9.06	99	897		Jun 17 11:58 AM
Che Austin	Officer	Jun 16 '25	Proposed Sale	9.04	99	895		Jun 16 10:21 AM
Che Austin	Officer	Jun 13 '25	Proposed Sale	8.92	99	883		Jun 13 10:04 AM
Che Austin	Officer	Jun 12 '25	Proposed Sale	9.51	99	941		Jun 12 09:45 AM
Che Austin	Officer	Jun 11 '25	Proposed Sale	8.93	99	884		Jun 11 09:58 AM
Che Austin	Officer	Jun 10 '25	Proposed Sale	7.99	99	791		Jun 10 10:07 AM
Che Austin	Officer	Jun 09 '25	Proposed Sale	7.75	99	767		Jun 09 10:01 AM

WVE

Wave Life Sciences Ltd

PACB

Pacific Biosciences of California Inc

DNA

Ginkgo Bioworks Holdings Inc

Upgrade your Finviz experience